Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
eHandbooks & White Papers
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Industry News
KV Pharma Sues Former CEO (First Chief to be Barred From Industry)
Marc Hermelin is the first drug company executive to be banned from participating in federal health care programs by the Department of Health and Human Services.
Oct. 19, 2011
Add Us On Google
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Ori Biotech
Ori Biotech IRO platform for cell and gene therapy manufacturing
Industry News
Ori Biotech partners with Europlaz on consumable supply
wuxibiologics
Contract Manufacturing
Role of CDMOs in the next era of biologics commercialization
You May Also Like
Industry News
Alexion buys biopharma Portola in $1.4 billion deal
Industry News
Collegium buys BioDelivery Sciences in $604M deal
Facility Design & Management
Eli Lilly breaks ground on $3.5B Pennsylvania site for next-generation obesity medicines
Load More Content